Carriers and Antigens: New Developments in Glycoconjugate Vaccines

Glycoconjugate vaccines have proven their worth in the protection and prevention of infectious diseases. The introduction of the Haemophilus influenzae type b vaccine is the prime example, followed by other glycoconjugate vaccines. Glycoconjugate vaccines consist of two components: the carrier prote...

Descripción completa

Detalles Bibliográficos
Autores principales: van der Put, Robert M.F., Metz, Bernard, Pieters, Roland J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9962112/
https://www.ncbi.nlm.nih.gov/pubmed/36851097
http://dx.doi.org/10.3390/vaccines11020219

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9962112/
https://www.ncbi.nlm.nih.gov/pubmed/36851097
http://dx.doi.org/10.3390/vaccines11020219

Ejemplares similares